[PTGX] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[PTGX] Protagonist Therapeutics, Inc.
Announcement Date
08-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 25.77%
YoY- 10.78%
Quarter Report
PTGX's Result
PTGX's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 0 0 0 0 859 25,722 8,617 -
PBT -38,460 -33,725 -34,194 -31,232 -41,037 -20,930 -36,907 2.79%
Tax -3,913 -2,296 -2,909 -1,071 -406 -181 -832 181.50%
NP -38,460 -31,429 -31,285 -30,161 -40,631 -20,749 -36,907 2.79%
Tax Rate - - - - - - - -
Total Cost 38,460 31,429 31,285 30,161 41,490 46,471 45,524 -10.66%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 -4,730.03 -80.67 -428.30 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.68 -0.62 -0.64 -0.62 -0.83 -0.43 -0.77 -7.97%
EPS Diluted -0.68 -0.62 -0.64 -0.61 -0.83 -0.43 -0.77 -7.97%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.